Transdermal Diagnostics Picks Up £1.1M for Its Needle-free Continuous Glucose Monitor
Transdermal Diagnostics, a University of Bath spinout company developing technology to monitor glucose levels non-invasively, has received £800K in seed funding and a £300K grant from Innovate UK. The seed round was led by QUBIS, which specialises in innovation focused spin-out companies, and includes Pioneer Group, Immetric, Bristol Private Equity Club and Science Angel Syndicate.
Read More from the Global Wellness News ™